Stopping menopausal hormone therapy: If breast cancer really decreased, why did colorectal cancer not increase?

Maturitas

Volumn 71, Issue 4, 2012, Pages 354-359

  Nahum, Gerard G ^a   Stanislaw, Harold ^b   Simon, James A ^c,d  

^a BAYER CORPORATION   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d Women's Health and Research Consultants   (United States)

Author keywords

Colorectal cancer; Combined estrogen plus progestogen therapy; Estrogen therapy; Hormone therapy; Invasive breast cancer; Menopause; Postmenopausal status

Indexed keywords

ESTROGEN; GESTAGEN;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MARKETING; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RISK; POSTMENOPAUSE; PRESCRIPTION; RISK ASSESSMENT;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; INCIDENCE; PROGESTINS; RISK FACTORS;

EID: 84858081426     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.01.002     Document Type: Article

References (21)

1. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333 (Pubitemid 34761611)
2. R.T. Chlebowski, S.L. Hendrix, and R.D. Langer Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial JAMA 289 2003 3243 3253 (Pubitemid 37430077)
3. Steering Committee for the Women's Health Initiative Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
4. M.L. Stefanick, G.L. Anderson, and K.L. Margulis Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy JAMA 295 2006 1647 1657
5. A.Z. LaCroix, R.T. Chlebowski, and J.E. Manson Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial JAMA 305 2011 1305 1314
6. J.S. Haas, D.L. Miglioretti, and B. Geller Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use J Gen Intern Med 22 2007 68 73 (Pubitemid 47308798)
7. Information derived by Bayer HealthCare from data provided by Wolters Kluwer Health, Source (R) Retail data; 2001-2008.
8. P.M. Ravdin, K.A. Cronin, N. Howlander, R.T. Chlebowski, and D.A. Berry A sharp decrease in breast cancer incidence in the United States in 2003, 29th Annual San Antonio Breast Cancer Symposium Breast Cancer Res Treat 100 Suppl. 1 2006 S6
9. P.M. Ravdin, K.A. Cronin, and N. Howlander The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 2007 1670 1674 (Pubitemid 46631679)
10. R.T. Chlebowski, J. Wactawski-Wende, and C. Ritenbaugh Estrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med 350 2004 991 1004 (Pubitemid 38269276)
11. SEER Fast Stats. Available at http://seer.cancer.gov/faststats/ selections.php?series=cancer.
12. G.G. Nahum, H. Stanislaw, and J.A. Simon The breast cancer incidence after initial publication of the WHI results: the colorectal cancer inconsistency Reprod Sci 18 4 Suppl. 2011 126A 127A
13. A.G. Glass, J.V. Lacey, J.D. Carreon, and R.N. Hoover Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status J Natl Cancer Inst 99 2007 1152 1161 (Pubitemid 47233065)
14. J.A. Simon, G.G. Nahum, H. Stanislaw, and T. Ignatovych The breast cancer plunge after initial publication of the WHI results: an alternative explanation Maturitas 66 2010 277 284
15. A. Gompel, and G. Plu-Bureau Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy Ann NY Acad Sci 1205 2010 268 276
16. M. Dietel, M.A. Lewis, and S. Shapiro Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review Hum Reprod 20 2005 2052 2060 (Pubitemid 41418488)
17. SEER Incidence Site Recode. Available at http://seer.cancer.gov/ siterecode/index.html.
18. J.P.A. Ioannidis Why most published research findings are false PLoS Med 2 8 2005 e124
19. J. Zhang, and K.F. Yu What's the relative risk. A method of correcting the odds ratio in cohort studies of common outcomes JAMA 280 1998 1690 1691 (Pubitemid 28532993)
20. L.A. McNutt, C. Wu, X. Wue, and J.P. Hafner Estimating the relative risk in cohort studies and clinical trials of common outcomes J Epidemiol 157 2003 940 943 (Pubitemid 36555054)
21. S. Simon Understanding the odds ratio and the relative risk J Androl 22 2001 533 536 (Pubitemid 32623072)